Roland Jimenez

KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia

Robert A. Hauser, Stewart A. Factor, Stephen R. Marder et al. · American Journal of Psychiatry · 2017 · 394 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study

Christopher O’Brien, Roland Jimenez, Robert A. Hauser et al. · Movement Disorders · 2015 · 130 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix

R. Scott Struthers, Andrew Nicholls, John S. Grundy et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 123 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

Michael P. Diamond, Bruce R. Carr, W. Paul Dmowski et al. · Reproductive Sciences · 2013 · 120 citations

Medicine, Gynecology, Obstetrics +12

No Effect of the Altered Peptide Ligand NBI-6024 on β-Cell Residual Function and Insulin Needs in New-Onset Type 1 Diabetes

Markus Walter, Areti Philotheou, F Bonńici et al. · Diabetes Care · 2009 · 117 citations · Full text

Medicine, Endocrinology, Pharmacology +17